NKGen Biotech Statistics
Total Valuation
NKGen Biotech has a market cap or net worth of $25.64 million. The enterprise value is $45.29 million.
Market Cap | 25.64M |
Enterprise Value | 45.29M |
Important Dates
The next estimated earnings date is Tuesday, May 28, 2024, before market open.
Earnings Date | May 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NKGen Biotech has 22.49 million shares outstanding. The number of shares has increased by 142.70% in one year.
Shares Outstanding | 22.49M |
Shares Change (YoY) | +142.70% |
Shares Change (QoQ) | +15.14% |
Owned by Insiders (%) | 60.49% |
Owned by Institutions (%) | 29.84% |
Float | 6.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
Current Ratio | 0.05 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -110.34 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -416.00% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.32M |
Employee Count | 63 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, NKGen Biotech has paid $7,000 in taxes.
Income Tax | 7,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.02% in the last 52 weeks. The beta is 0.44, so NKGen Biotech's price volatility has been lower than the market average.
Beta (1Y) | 0.44 |
52-Week Price Change | -89.02% |
50-Day Moving Average | 1.58 |
200-Day Moving Average | 3.90 |
Relative Strength Index (RSI) | 40.68 |
Average Volume (30 Days) | 3,651,045 |
Short Selling Information
The latest short interest is 550,662, so 2.45% of the outstanding shares have been sold short.
Short Interest | 550,662 |
Short Previous Month | 423,773 |
Short % of Shares Out | 2.45% |
Short % of Float | 8.35% |
Short Ratio (days to cover) | 2.08 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.75M |
Pretax Income | -82.95M |
Net Income | -82.95M |
EBITDA | -80.64M |
EBIT | -82.20M |
Earnings Per Share (EPS) | -$5.38 |
Balance Sheet
The company has $276,000 in cash and $19.92 million in debt, giving a net cash position of -$19.65 million or -$0.87 per share.
Cash & Cash Equivalents | 276,000 |
Total Debt | 19.92M |
Net Cash | -19.65M |
Net Cash Per Share | -$0.87 |
Equity / Book Value | -58.69M |
Book Value Per Share | -2.61 |
Working Capital | -37.52M |
Cash Flow
In the last 12 months, operating cash flow was -$21.95 million and capital expenditures -$48,000, giving a free cash flow of -$22.00 million.
Operating Cash Flow | -21.95M |
Capital Expenditures | -48,000 |
Free Cash Flow | -22.00M |
FCF Per Share | -$1.43 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NKGen Biotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -142.70% |
Shareholder Yield | -142.70% |
Earnings Yield | -323.48% |
FCF Yield | -85.77% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |